IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tevogen BIO Holdings Inc (TVGN)

CUSIP: 88165K101 | NYSE | Healthcare · Biotechnology | Micro Cap | 76 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ASaadi Ryan H.3,709,56759.7%−120,818,809Jul 10, 2026No 13F filer matched
13D/ASaadi Ryan H.3,709,567
59.7% of class · Jul 10, 2026

Institutional Holders — Q1 2026

Vanguard Group Inc0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Vanguard Group Inc
0$00.0%N/AN/AValley Forge, PA2026-05-14
−120,818,809
No 13F filer matched